Table 7.

Previous major publications of CML in BT

AuthorNo.Overall response, %Median survival, moPrognostic factors
Coleman et al, 19808 202 34 Response to therapy  
Kantarjian et al, 198726 242 36 4.5 Hemoglobin, platelets, BM blasts, type of BT, clonal evolution  
Anger et al, 19886 69 40 2.5 Clonal evolution, type of BT, BM blasts + promyelocytes, response to therapy  
Derderian et al, 199314 296 20 Type of BT 
 (LBC-68) (49) (9)  
Griesshammer et al, 199629 90 29 2.8 Response to therapy, presence of trisomy 8  
Sacchi et al, 19991 162 22 5.5 Decitabine therapy particularly in older patients  
Present study 78 46 8.2 Cytogenetic evolution, PB blasts 
AuthorNo.Overall response, %Median survival, moPrognostic factors
Coleman et al, 19808 202 34 Response to therapy  
Kantarjian et al, 198726 242 36 4.5 Hemoglobin, platelets, BM blasts, type of BT, clonal evolution  
Anger et al, 19886 69 40 2.5 Clonal evolution, type of BT, BM blasts + promyelocytes, response to therapy  
Derderian et al, 199314 296 20 Type of BT 
 (LBC-68) (49) (9)  
Griesshammer et al, 199629 90 29 2.8 Response to therapy, presence of trisomy 8  
Sacchi et al, 19991 162 22 5.5 Decitabine therapy particularly in older patients  
Present study 78 46 8.2 Cytogenetic evolution, PB blasts 

LBC indicates lymphoid blastic crisis.

Close Modal

or Create an Account

Close Modal
Close Modal